Moderna
MRNA
#1830
Rank
HK$84.25 B
Marketcap
HK$215.63
Share price
8.67%
Change (1 day)
-37.63%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: HK$84.25 Billion

As of December 2025 Moderna has a market cap of HK$84.25 Billion. This makes Moderna the world's 1830th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$84.25 B-29.72%
2024HK$119.88 B-59.52%
2023HK$296.14 B-45.07%
2022HK$539.16 B-32.85%
2021HK$802.96 B150.55%
2020HK$320.47 B525.11%
2019HK$51.26 B30.39%
2018HK$39.31 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Moderna was reported to be:

HK$84.24 Billion
by Nasdaq info icon info icon
HK$84.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
HK$4.39 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.938 T 2,201.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.48 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$471.14 B 459.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.974 T 2,242.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
HK$66.12 B-21.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.787 T 4,395.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.17 B-72.49%๐Ÿ‡บ๐Ÿ‡ธ USA